Shanghai Allist Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 95.72

Shanghai Allist Pharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 3.61% on March 5, 2026. The stock reached an intraday low of CNY 95.72, reflecting a significant movement in the market. In terms of performance metrics, the company has shown resilience over the past year, achieving a return of 21.32%, although this is slightly below the China Shanghai Composite's return of 22.49%. Year-to-date, Shanghai Allist's performance has been less favorable, with a decline of 7.4% compared to the composite index's gain of 2.85%. Despite today's downturn, the company has demonstrated strong financial health, reporting a net profit of CNY 1,187.76 million, which has grown by 59.72%. The operating cash flow reached its highest at CNY 2,163.79 million, and the return on equity stands at an impressive 29.94%. With a market capitalization of CNY 43,056 million, Shanghai Allist remains a significant player in the pharmaceuticals and biotechnology sector.